💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @Tickeron | 4 |
| @TradingChromat1 | 3 |
| @ZskiTexas | 3 |
| @shortablestocks | 1 |
| @ShortAlgoTrades | 1 |
Recent Tweets for GNCA
 |
@shortablestocks $GNCA is short sale restricted for 2021-12-03. https://t.co/UUDD1fck7b December 3rd 2021, 2:12pm |
 |
@brendan_49 $GNCA expands TILs (actually peripheral T cells) from dendritic cells that engulfed E. coli that express patient sp… https://t.co/EX0cFtqesc December 2nd 2021, 8:12pm |
 |
@TradingChromat1 Awaiting Buy signal on $GNCA https://t.co/HQJ7IFOo5p December 2nd 2021, 4:12pm |
 |
@ZskiTexas $GNCA Way undervalued. https://t.co/aFFga9SssE December 1st 2021, 4:12pm |
 |
@Tickeron $GNCA's price moved below its 50-day Moving Average on November 4, 2021. View odds for this and other indicators:… https://t.co/BJ6t53tbKt December 1st 2021, 12:12am |
|
@Tickeron A.I.dvisor made a bearish call on $GNCA, netting in a 27.18% gain over 2 months #GenoceaBiosciences #stockmarket… https://t.co/1E4eRpHf6d November 30th 2021, 10:11pm |
|
@ZskiTexas $GNCA collaboration with UMass Med. Ctr., “Study of Immune Responses to COVID-19”. https://t.co/RWXakY0zAe https://t.co/3IGmn9wotU November 30th 2021, 5:11pm |
 |
@Ahmadjaber2499 $GNCA Not selling here. I have a $3-5 price target by February- April. November 30th 2021, 4:11pm |
 |
@ShortAlgoTrades $GNCA Awaiting buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp #Investing #trading https://t.co/M51DXXMQeJ November 30th 2021, 12:11pm |
|
@TradingChromat1 Awaiting Buy signal on $GNCA https://t.co/XLro42oQtt November 29th 2021, 5:11pm |
|
@ZskiTexas $GNCA Way undervalued. #Biotech $IBB #Cancer #Immunotherapy https://t.co/XsyQhC1XSV November 23rd 2021, 2:11pm |
|
@TradingChromat1 Awaiting Buy signal on $GNCA https://t.co/f0ZPUUBrhB November 22nd 2021, 4:11pm |
|
@Tickeron $GNCA enters a Downtrend because Momentum Indicator dropped below the 0 level on November 11, 2021. View odds for t… https://t.co/WZLv6jo3G4 November 22nd 2021, 12:11pm |
|
@Tickeron $GNCA enters a Downtrend as Momentum Indicator dropped below the 0 level on November 11, 2021. View odds for this a… https://t.co/u3d937YmZw November 21st 2021, 10:11pm |
|
@TradingChromat1 Awaiting Buy signal on $GNCA https://t.co/bpQteT3qi0 November 19th 2021, 1:11pm |
|
@ZskiTexas RT @Ahmadjaber2499: Low caps getting decimated… I’m chillin. Historically things go parabolic in December. Still holding full in $GNCA $PMC… November 18th 2021, 3:11pm |
 |
@Eminatorus RT @ZskiTexas: $GNCA Stifel 2021 Virtual Healthcare Conference Nov 17, 2021 1:20 PM EST. #Stifel November 17th 2021, 2:11pm |
|
@TradingChromat1 Awaiting Buy signal on $GNCA https://t.co/7BTuMWZ3Jw November 17th 2021, 2:11pm |
|
@ZskiTexas $GNCA Big Update: Dana Farber, Memorial Sloan Kettering, and Moffitt Cancer Center added to institutions participat… https://t.co/DuphIy5NdU November 17th 2021, 1:11pm |
|
@ZskiTexas $GNCA Stifel 2021 Virtual Healthcare Conference Nov 17, 2021 1:20 PM EST. #Stifel November 16th 2021, 6:11pm |
|
@shortablestocks The short volume for $GNCA increased by 45.39 percentage points from 2021-11-10 to 2021-11-11.… https://t.co/e3Ue0k0KfQ November 12th 2021, 12:11pm |
 |
@StockTipRobot Berkshire Hathaway's janitor's cousin told me to sell Genocea Biosciences $GNCA #StockTip November 12th 2021, 10:11am |
 |
@1stOncology #Genocea to Present at the #StifelVirtualHealthcareConference $GNCA https://t.co/93zyTOhzdW November 12th 2021, 8:11am |
|
@ZskiTexas RT @FlashAlert_me: $GNCA [15s. delayed]: Issued Press Release on November 10, 19:26:00: Genocea to Present at the Stifel 2021 Virtual Healt… November 11th 2021, 12:11am |
 |
@StckPro $GNCA NEW ARTICLE : Genocea to Present at the Stifel 2021 Virtual Healthcare Conference https://t.co/RKPIqh4343 Get… https://t.co/BhYZC8RMa8 November 11th 2021, 12:11am |
 |
@FlashAlert_me $GNCA [15s. delayed]: Issued Press Release on November 10, 19:26:00: Genocea to Present at the Stifel 2021 Virtual… https://t.co/stTLDMh1rj November 11th 2021, 12:11am |
 |
@StockNewsBot2 $GNCA Genocea to Present at the Stifel 2021 Virtual Healthcare Conference https://t.co/Gu8q2upCRB November 11th 2021, 12:11am |
 |
@quantisnow $GNCA ? Genocea to Present at the Stifel 2021 Virtual Healthcare Conference https://t.co/12H6CThHVe 45 seconds delayed. November 11th 2021, 12:11am |
 |
@newsfilterio Genocea to Present at the Stifel 2021 Virtual Healthcare Conference $GNCA https://t.co/r4kAx5DYrp November 11th 2021, 12:11am |
 |
@stock_titan $GNCA Genocea to Present at the Stifel 2021 Virtual Healthcare Conference https://t.co/3iAEcAgXIm November 11th 2021, 12:11am |
 |
@elihaus82 @StevenKS12 @MrZackMorris Appreciate it. Another I like is $GNCA. November 10th 2021, 11:11pm |
|
@elihaus82 @MrZackMorris What about $GNCA ? November 10th 2021, 9:11pm |
|
@ZskiTexas @PropThinker @brendan_49 Slides from GEN-011 manufacturing process (PLANET) Pres’n (2/2) $GNCA… https://t.co/KdIxKhPJfF November 8th 2021, 3:11pm |
|
@ZskiTexas @PropThinker @brendan_49 Slides from GEN-011 manufacturing process (PLANET) Pres’n (1/2) $GNCA… https://t.co/NDY0RWwLZk November 8th 2021, 3:11pm |
 |
@PropThinker @brendan_49 Up to 90% of T-cells in TIL are bystander (no specificity). $GNCA claims to deliver 10-100s of million… https://t.co/xnNxrivNaO November 8th 2021, 3:11pm |
 |
@Johnkak4 RT @bkfViking123: $gnca TiTAN™ clinical trial for GEN-011, our neoantigen-targeted peripheral T cell therapy (NPT) candidate, from which we… November 7th 2021, 6:11am |
|
@ZskiTexas $GNCA 100-bagger. Hidden gem with disruptive tech (ATLAS). November 5th 2021, 6:11pm |
|
@ZskiTexas RT @ALAMOCiTYTRADER: @ski_helmet $GNCA a sleeping giant November 4th 2021, 11:11pm |
 |
@ALAMOCiTYTRADER @ski_helmet $GNCA a sleeping giant November 4th 2021, 10:11pm |
|
@TradingChromat1 $GNCA Awaiting Buy signal on GNCA https://t.co/2e1Qhf54Ac November 4th 2021, 4:11pm |
|
@ShortAlgoTrades $GNCA Awaiting Buy signal on GNCA https://t.co/WGCLz2xkE5 November 3rd 2021, 3:11pm |
|
@TradingChromat1 $GNCA Awaiting Buy signal on GNCA https://t.co/wcLQyZRmtP November 3rd 2021, 3:11pm |
|
@ZskiTexas Highly visible & transparent: $GNCA Genocea’s GEN-011 manufacturing process: “GEN-011 PLANET Process: A Robust an… https://t.co/vYRt9dE1L2 October 29th 2021, 3:10pm |
 |
@AaronRosenblum5 @brendan_49 I agree which is why I don’t have a position now, but $gnca has some serious investors so I think those… https://t.co/1mYmAxH8Jk October 29th 2021, 2:10pm |
|
@ZskiTexas $GNCA Genocea, Huge presence at upcoming #SITC21. 5 Poster Presn’s. UNDERVALUED. https://t.co/cFP6kn9qg1 https://t.co/UTZmgfWqkL October 29th 2021, 2:10pm |
|
@AaronRosenblum5 @brendan_49 Why do you prefer them so strongly to $gnca. No position and I don’t like the delays in data, they will… https://t.co/yPNGwaCFNw October 29th 2021, 2:10pm |
 |
@CSIMarket Sales Weak, $GNCA #Stocks #GenoceaBiosciences released Results for the time frame financial report: For the most re… https://t.co/mNuDDBSJJ2 October 29th 2021, 2:10pm |
|
@ZskiTexas $GNCA Q3’21 Earnings Call Transcript out. Highly encourage investors and those still sitting on the fence to read.… https://t.co/EusK0nNUpN October 28th 2021, 5:10pm |
 |
@SeekingAlpha $GNCA - Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2021 Results - Earnings Call Transcript.… https://t.co/kcTvBIsAzP October 28th 2021, 5:10pm |
 |
@stockwatcherapp $GNCA is up 10.18% to $1.84 October 28th 2021, 4:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?